MOG and epilepsy: Furthermore, a subset of patients in the remaining patients with AQP4 antibody-seronegative NMOSD who presented with fever, headache, epilepsy, and imaging meningeal involvement were found to be positive for the myelin oligodendrocyte glycoprotein (MOG) antibody.